In this issue:
ACEIs and ARBs do not increase COVID-19 risk
CV disease risk assessment for Aboriginal and Torres Strait Islanders
CETP inhibitors and CV outcomes
Oral anticoagulant use in AF patients with prior gastrointestinal bleeding
Atorvastatin reduces recurrent vascular events: the SPARCL trial
Long-term outcomes after PCI in women vs men
Use of rivaroxaban after lower extremity revascularisation in patients with PAD
Clinical effectiveness of primary prevention implantable defibrillators
Atrial septal aneurysm, shunt size, and recurrent stroke in PFO patients
Incidence and implications of AF/flutter in hypertension
Please login below to download this issue (PDF)